CCRN vs. MD, AMN, LH, DGX, DVA, CHE, CRVL, AMED, BBSI, and KFRC
Should you be buying Cross Country Healthcare stock or one of its competitors? The main competitors of Cross Country Healthcare include Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Amedisys (AMED), Barrett Business Services (BBSI), and Kforce (KFRC).
Cross Country Healthcare vs.
Cross Country Healthcare (NASDAQ:CCRN) and Pediatrix Medical Group (NYSE:MD) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, community ranking, dividends, earnings, profitability and institutional ownership.
Cross Country Healthcare has higher earnings, but lower revenue than Pediatrix Medical Group. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Pediatrix Medical Group, indicating that it is currently the more affordable of the two stocks.
Cross Country Healthcare has a beta of 0.44, suggesting that its stock price is 56% less volatile than the S&P 500. Comparatively, Pediatrix Medical Group has a beta of 1.49, suggesting that its stock price is 49% more volatile than the S&P 500.
In the previous week, Cross Country Healthcare had 8 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 11 mentions for Cross Country Healthcare and 3 mentions for Pediatrix Medical Group. Pediatrix Medical Group's average media sentiment score of 1.59 beat Cross Country Healthcare's score of 1.48 indicating that Pediatrix Medical Group is being referred to more favorably in the news media.
Cross Country Healthcare has a net margin of -0.12% compared to Pediatrix Medical Group's net margin of -4.92%. Pediatrix Medical Group's return on equity of 15.47% beat Cross Country Healthcare's return on equity.
Pediatrix Medical Group received 36 more outperform votes than Cross Country Healthcare when rated by MarketBeat users. However, 63.31% of users gave Cross Country Healthcare an outperform vote while only 60.21% of users gave Pediatrix Medical Group an outperform vote.
Cross Country Healthcare currently has a consensus target price of $18.41, suggesting a potential upside of 22.71%. Pediatrix Medical Group has a consensus target price of $17.08, suggesting a potential upside of 20.71%. Given Cross Country Healthcare's higher probable upside, equities analysts clearly believe Cross Country Healthcare is more favorable than Pediatrix Medical Group.
96.0% of Cross Country Healthcare shares are held by institutional investors. Comparatively, 97.7% of Pediatrix Medical Group shares are held by institutional investors. 4.9% of Cross Country Healthcare shares are held by insiders. Comparatively, 2.0% of Pediatrix Medical Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
Pediatrix Medical Group beats Cross Country Healthcare on 11 of the 18 factors compared between the two stocks.
Get Cross Country Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for CCRN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Cross Country Healthcare Competitors List
Related Companies and Tools
This page (NASDAQ:CCRN) was last updated on 3/28/2025 by MarketBeat.com Staff